2023 Cardio-Oncology Symposium

Friday, April 28, 2023

Conference starts in:

The Ohio State University Medical Center - Columbus, OH
1 Day Conference April 28th, 2023
7.25 AMA PRA Category 1 Credit Hours


The 2023 Cardio-Oncology Symposium addresses important clinical topics relevant to the cardiovascular health of patients with cancer. The symposium faculty will discuss new cancer treatments and strategies in diagnosis and management of cardiovascular disease in cancer patients from early diagnosis, treatment and long-term surveillance.  It is anticipated that this CME activity will Improve care for cardio-oncology patients by understanding the short-term and delayed onset cardiotoxic effects of emerging cancer therapies. In addition, identifying when cardiovascular disease issues develop with cancer patient treatment strategies can be implemented more promptly.  Case scenarios will be central to this educational activity.


For pricing information, see pricing tab below.

Dates and Times

Start: 4/28/2023 7:50 AM
End: 4/28/2023 4:15 PM


At the conclusion of the continuing medical education activity participants should be able to:

1. Define the short-term and long-term cardiotoxic effects of contemporary cancer therapies.
2. Identify the best strategies to recognize when cardiovascular issues develop with your cancer patient.
3. Describe the role of cardioprotective therapy in your cancer patient population.
4. Compare cardiac imaging modalities to determine the optimal test for specific cancer patients.
5. Identify and integrate emerging cardio-oncology guidelines in clinical practice.
6. Recognize advancements and challenges in diagnosing and managing cardiac amyloidosis.


Moderators: Daniel Addison, MD and Bhuvaneswari Ramaswamy, MD, MRCP
Module 1
7:50 am     Welcome and housekeeping remarks
                           Ayesha Hasan, MD and Raphael Pollock, MD, PhD

8:00           Managing Acute Coronary Syndromes in Cancer Patients
                          Dean Boudoulas, MD

8:15           Cardiac Ablation Therapy in Cancer Patients
                           Mahmoud Houmsse, MD

8:30           Cardiotoxicity after Cellular (CAR-T Cell) Therapies
                          Jonathan Brammer, MD

8:45           BTK inhibitor-induced Cardiac Arrhythmias
                          Adam Kittai, MD

9:00           New Directions of Genetics within Cardio-Oncology
                         Ray Hershberger, MD

9:15            Uses of STRAIN Imaging in Patients with Cancer
                         Adam Potter, MD

9:30            Addressing Cardiovascular Risk in Diverse Prostate Cancer Populations
                         Avirup Guha, MD, RPVI

9:45            Preventing and Managing Radiation associated CVD
                        Eric Miller, MD, PhD

10:00       Break

Module 2
10:10           Cardiovascular Toxicities of Immune Checkpoint Inhibitors
                        Ajay Vallakati, MBBS

10:25         Emerging Mechanisms of Tyrosine Kinase Inhibitor Cardiac Toxicity
                        Sakima Smith, MD, MPH

10:40         Managing Chronic CAD in the Cancer Patient
                       Richard Gumina, MD, PhD

10:55         Addressing Disparities in Cardio-Oncology Populations
                       Arnethea Sutton, PhD

11:10           Use of Advanced Cardiac Imaging in the Cancer Patient
                       Daniel Addison, MD

11:25         Managing Hypertension associated with Cancer Therapies
                     Jason Prosek, MD

11:40         Cardio-Oncology Needs from the Perspective of an Oncologist
                     Bhuvaneswari Ramaswamy, MD, MRCP

11:55         New Insights into the role of CHIP mutations and the Risk of Cardiovascular Disease
                     Uma Borate, MD, MS

Module 3
Breakout Sessions:
12:55 pm   Welcome and housekeeping – Dr. Addison

Breakout A – Cardiac Complications of Cancer Immune Therapies – emerging role of Imaging
                 Paaladinesh Thavendiranathan, MD, Avirup Guha, MD, MPH, Alexa Meara, MD, and Ajay Vallakati, MBBS

1:00         Case Scenario (immune Checkpoint Myocarditis)
                    Timothy Gauntner, DO, PhD

1:05         Case Scenario (CAR-T cell induced heart failure) 

1:10          Panel Discussion of Cases
                    Avirup Guha, MD, RPVI, Alexa Meara, MD, and Ajay Vallakati, MBBS.

1:30         Keynote Lecture: Immunotherapy-associated Cardiotoxicity -Where are We Going
                    Paaladinesh Thavendiranathan, MD

Breakout B – Novel Cancer Targeted and Immune Therapy associated Cardiotoxicities
              Daniel Addison, MD, Zachary Braunstein, MD, Mahmoud Houmsse, MD, and Jonathan Brammer, MD

2:00         Case Scenarios (BTKI associated Atrial Fibrillation) 

2:05         Case Scenarios (Stem cell transplant associated heart failure) 

2:10         Panel Discussion:
                     Daniel Addison, MD, Nausheen Akhter, MD, Mahmoud Houmsse, MD, and Jonathan Brammer, MD

2:30         Keynote Lecture: Novel Targeted Therapy associated cardiotoxicities- how do we screen and management these events?
                    Nausheen Akhter, MD

3:00        Break

Breakout C – Cardiac Amyloidosis in the 21st Century
              Naresh Bumma, MD, Rami Kahwash, MD, Courtney Campbell, MD PhD, CV Fellow, MD

3:15        Case Scenarios (Indeterminate PYP Imaging, and course of care) 

3:20        Case Scenarios (CHF in Myeloma, and Orthopedic associations) -

3:25       Panel Discussion:
                   Naresh Bumma, MD, Rami Kahwash, MD, Courtney Campbell, MD, PhD

3:45       Keynote: New Directions in Cardiac Amyloidosis Treatment 

4:15      Meeting Adjournment
                   Daniel Addison, MD


Tier Price
Physician, attending in person $0.00
Nurse/Nurse Practitioner, attending in person $0.00
Allied Medical Professional, attending in person $0.00
Other, attending in person $0.00
Physician. participating online $0.00
Nurse/Nurse Practitioner, participating online $0.00
Allied Health Professional, participating online $0.00
Other, participating online $0.00


The Ohio State University Medical Center
Biological Research Tower
460 W. 12th Avenue
Columbus, OH 43210


The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Need help with this Conference?

Please contact the Conference coordinator listed below:

Ellen Yokoyama
Department: Heart and Vascular Center
Phone: (614) 293-7161
Email: Ellen.Yokoyama@osumc.edu